Conexeu Sciences Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024
Cash & Equivalents	6.26	4.81	0.31
Short-Term Investments	0.07	0.07	-
Cash & Short-Term Investments	6.33	4.88	0.31
Cash Growth	1910.93%	1451.19%	-
Other Receivables	-	0	-
Total Trade Receivables	-	0	-
Other Current Assets	1.13	2.58	0.03
Total Current Assets	7.46	7.46	0.35
Net Property, Plant & Equipment	0.01	0.01	-
Other Intangible Assets	0.17	0.18	0.19
Other Long-Term Assets	0.06	0.04	-
Total Assets	7.7	7.69	0.53
Accounts Payable	0.4	0.26	0.33
Accrued Expenses	-	0.08	-
Other Current Liabilities	0.48	0	0.01
Total Current Liabilities	0.88	0.34	0.34
Total Liabilities	0.88	0.34	0.44
Common Stock	0.02	0.02	0.01
Additional Paid-in Capital	13.05	11.86	0.68
Retained Earnings	-6.24	-4.52	-0.6
Shareholders' Equity	6.83	7.35	0.09
Total Liabilities & Equity	7.7	7.69	0.53

SEC Filings: 10-K · 10-Q